Personalized Medicine Biomarkers Market Size, Share & Trends Analysis Report By Application (Early Detection, Treatment Selection, Monitoring), By Indication (Oncology, Neurology), By Region, And Segment Forecasts, 2025 - 2030
- Report ID: GVR-4-68039-996-3
- Number of Report Pages: 120
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2024
- Forecast Period: 2025 - 2030
- Industry: Healthcare
Market Segmentation
- Personalized Medicine Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Personalized Medicine Biomarkers Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Personalized Medicine Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- North America Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- U.S.
- U.S. Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- U.S. Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- U.S. Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Canada
- Canada Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Canada Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Canada Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Mexico
- Mexico Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Mexico Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Mexico Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- North America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Europe
- Europe Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Europe Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- UK
- UK Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- UK Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- UK Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Germany
- Germany Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Germany Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Germany Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- France
- France Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- France Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- France Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Italy
- Italy Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Italy Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Italy Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Spain
- Spain Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Spain Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Spain Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Europe Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Asia Pacific
- Asia Pacific Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Asia Pacific Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Japan
- Japan Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Japan Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Japan Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- China
- China Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- China Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- China Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- India
- India Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- India Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- India Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Australia
- Australia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Australia Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Australia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- South Korea
- South Korea Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- South Korea Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- South Korea Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Asia Pacific Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Latin America
- Latin America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Latin America Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Brazil
- Brazil Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Brazil Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Brazil Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Argentina
- Argentina Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Argentina Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Argentina Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Latin America Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- MEA
- MEA Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- MEA Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- South Africa
- South Africa Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- South Africa Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- South Africa Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Saudi Arabia
- Saudi Arabia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Saudi Arabia Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Saudi Arabia Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- UAE
- UAE Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- UAE Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- UAE Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Kuwait
- Kuwait Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- Early Detection/Screening
- Diagnosis
- Treatment Selection
- Monitoring
- Kuwait Personalized Medicine Biomarkers Market, By Indication, 2018 - 2030 (USD Million)
- Oncology
- By Type
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Others
- By Circulating Biomarkers
- Circulating Tumor Cells(CTCs)
- Circulating Cell-free DNA(cfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- By Type
- Neurology
- Diabetes
- Autoimmune Diseases
- Cardiology
- Others
- Oncology
- Kuwait Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- MEA Personalized Medicine Biomarkers Market, By Application 2018 - 2030 (USD Million)
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
